<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate the frequency and risk factors of <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> in a large cohort of patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Five hundred nineteen consecutive patients with SLE were studied, with follow-up ranging from 4 to 7.8 years </plain></SENT>
<SENT sid="2" pm="."><plain>The type and frequency of risk factors associated with <z:hpo ids='HP_0011009'>acute</z:hpo> and recurrent <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> in SLE were determined </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Sixty (11.6%) patients with <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> were identified </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">Epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> occurred at the <z:hpo ids='HP_0003674'>onset</z:hpo> of SLE symptoms in 19 (31.6%) and after the <z:hpo ids='HP_0003674'>onset</z:hpo> of SLE in 41 of 60 (68.3%) patients </plain></SENT>
<SENT sid="5" pm="."><plain>Fifty-three of 60 (88.3%) patients had <z:hpo ids='HP_0011009'>acute</z:hpo> symptomatic <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo>, and 7 of 60 (11.7%) had recurrent <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Variables associated with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> at SLE <z:hpo ids='HP_0003674'>onset</z:hpo> were <z:hpo ids='HP_0001297'>stroke</z:hpo> (p = 0.0004) and <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (p = 0.0013) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">Epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> during follow-up were related to <z:hpo ids='HP_0000123'>nephritis</z:hpo> (p = 0.001), <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (p = 0.005), and <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> at disease <z:hpo ids='HP_0003674'>onset</z:hpo> (p = 0.00001) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> seven patients who presented recurrent <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> had <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and interictal <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> abnormalities on EEG </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">Epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> were observed in 11.2% of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) patients </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo> were related to <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> at SLE disease <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Patients with renal flares, <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> at SLE disease <z:hpo ids='HP_0003674'>onset</z:hpo>, and <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> were at greater risk for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0011145'>symptomatic seizures</z:hpo> during follow-up </plain></SENT>
<SENT sid="12" pm="."><plain>Recurrence of <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> occurred in 1.3% of patients and was associated with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>